September 21, 2017 – PARIS — HRA Pharma, a fast-growing, innovative consumer healthcare company, announced today that it has completed the previously announced acquisition of the Compeed® brand from Cilag GmbH International, a Johnson & Johnson company. As part of the deal, the transfer of ownership from Cilag GmbH International to HRA Pharma is planned […]
Teva Announces Sale of Remaining Assets in Specialty Global Women’s Health Portfolio for $1.38 Billion
September 18, 2017 – JERUSALEM, ISREAL — Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced it has entered into two agreements to sell the remaining assets of its specialty global women’s health business for $1.38 billion. Proceeds from these sales, combined with proceeds from the recently announced sale of PARAGARD® total $2.48 billion […]
September – 28, 2017, New York – What an incredible month! Sawaya Partners Consumer Healthcare team is pleased to report the announcement and closing of three transactions with an aggregate transaction value of approximately $1.5 Billion. These three announcements emphasize the broad skill set of our team who: 1. Advised Foundation Consumer Healthcare and its two […]
November 28 – 30, 2017, LISBON — The 12th Ceuta International Alliance conference will be held in the city of Lissbon, November 28 – 30. The event will be attended by 147 delegates across the two days, including representatives from 22 leading manufacturers, key industry opinion leaders and Alliance Partners representing 4 continents. The theme of this […]
July 1st, 2017, New York, NY — Each year, thousands of athletes brave the waters of the mighty Hudson River before biking along Manhattan’s West Side highway. Finally, athletes put on their running shoes for a run through New York’s famed Central Park in the final stage of this iconic race.